Policy/Enforcement News
Prescription Drug Affordability Board Activity, October 2025
Prescription Drug Affordability Board Activity, October 2025 Activities Summary Colorado: Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting was rescheduled from November 14, 2025 to January 9, 2026. Maryland: The PDAB will next…
[...]Five takeaways from CNBC’s investigation of alternative funding programs
What are the most important lessons from CNBC’s documentary about alternative funding programs (AFPs)?
[...]PSM asks House Energy & Commerce Committee to oppose H.R. 5316, The Drug Shortage Compounding Patient Access Act
PSM sent a letter explaining how H.R. 5316 undermines critical patient safety protections.
[...]Prescription Drug Affordability Board Activity, September 2025
Prescription Drug Affordability Board Activity, September 2025 Activities Summary Colorado: Colorado’s next meeting will be October 3, 2025. Maryland: The PDAB met on September 29, 2025 to hear public comment about UPL-setting for Jardiance and Farxiga and to consider policy approaches to lower the costs of these drugs for Maryland patients. Oregon: The PDAB met…
[...]Oregon State Pharmacy Association makes the case for PBM reform, not payment limits
This summer, Brian Mayo, Executive Director of the Oregon State Pharmacy Association (OSPA), made the case for pharmacy benefit manager (PBM) reform as a better way to rein in drug prices.
[...]Why are price cap proposals on medicines dangerous to pharmacies and patients?
Supply chain complexity means that upper payment limits and Medicare maximum fair prices will fall disproportionately on pharmacies, leading to closures that threaten patient access to care.
[...]Med spas need stronger regulation
Medical spas and wellness clinics are operating on the edge of existing regulatory frameworks and it’s a risk to American patients.
[...]Prescription Drug Affordability Board Activity, August 2025
Prescription Drug Affordability Board Activity, August 2025 Activities Summary Colorado: Colorado’s PDAB met on August 22, 2025 for to continue rulemaking to set an upper payment limit for Enbrel, during which they heard substantial public comment. They will continue this process at their next meeting on October 3. Maryland: The next PDAB meeting will be…
[...]PSM leads letter in support of an FDA mandate to destroy high-risk imports
PSM led a coalition of organizations urging leaders of the Senate HELP and House Energy and Commerce committees to help strengthen the FDA’s ability to protect Americans from unsafe and counterfeit medicines and medical products.
[...]Prescription Drug Affordability Board Activity, July 2025
Prescription Drug Affordability Board Activity, July 2025 Activities Summary Colorado: Colorado’s PDAB met on July 11, 2025 for a rulemaking hearing to set an upper payment limit for Enbrel, during which they heard substantial public comment. They will continue this process at their next meeting on August 22. Maryland: At its July 28 meeting, Maryland’s…
[...]